Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

Genentech Implements Fourth Round of Layoffs Amid Ongoing Restructuring

Genentech Implements Fourth Round of Layoffs Amid Ongoing Restructuring

Genentech, a subsidiary of Swiss pharmaceutical giant Roche, has announced another wave of job cuts at its South San Francisco headquarters, marking the fourth round of layoffs in the past 15 months. The company is eliminating 87 positions, effective September 15, as revealed in a California Worker Adjustment and Retraining Notification (WARN) report filed last week.

NoahAI News7/24/2025
CDMO Industry Sees Mixed Results as Lonza Rebounds and Samsung Bio Maintains Growth

CDMO Industry Sees Mixed Results as Lonza Rebounds and Samsung Bio Maintains Growth

In a landscape marked by post-pandemic challenges, contract development and manufacturing organizations (CDMOs) are navigating a complex market with varying degrees of success. Recent financial reports from industry leaders Lonza and Samsung Biologics paint a picture of resilience and strategic adaptation in the face of changing market dynamics.

NoahAI News7/24/2025
Arrowhead Pharmaceuticals Reassures Investors Amid Sarepta Partnership Concerns

Arrowhead Pharmaceuticals Reassures Investors Amid Sarepta Partnership Concerns

Arrowhead Pharmaceuticals has moved to allay investor concerns regarding its partnership with Sarepta Therapeutics, affirming expectations that its troubled R&D collaborator will fulfill its financial commitments. The reassurance comes as Sarepta faces mounting challenges, prompting scrutiny of the $825 million deal struck in November.

NoahAI News7/24/2025
Sutter Health Appoints New Chief Operating Officer Amid Ongoing Expansion

Sutter Health Appoints New Chief Operating Officer Amid Ongoing Expansion

Sutter Health, a major healthcare system in Northern California, has announced the appointment of Kevin Manemann as its new chief operating officer (COO), effective September 15. This strategic move comes as part of a series of executive appointments aimed at strengthening the organization's leadership team and supporting its ambitious growth plans.

NoahAI News7/24/2025
Recall Alert: Orient Pharma and AvKARE Pull Nearly 80,000 Bottles of Cholesterol Drug

Recall Alert: Orient Pharma and AvKARE Pull Nearly 80,000 Bottles of Cholesterol Drug

In a significant move affecting the pharmaceutical industry, two companies have initiated recalls of the cholesterol-lowering medication pitavastatin due to quality concerns. Taiwanese manufacturer Orient Pharma and Tennessee-based AvKARE have collectively pulled almost 80,000 bottles from the market, citing failed impurity and degradation specifications.

NoahAI News7/24/2025
Aidoc Secures $150M in Funding to Expand Clinical AI Solutions

Aidoc Secures $150M in Funding to Expand Clinical AI Solutions

Healthcare AI company Aidoc has raised $150 million in new financing, aiming to expand its clinical AI solutions into oncology and cardiovascular disease. The funding round, led by General Catalyst and Square Peg, with participation from NVentures (NVIDIA's venture capital arm) and four major U.S. health systems, brings Aidoc's total funding to $370 million.

NoahAI News7/24/2025
Cost Pressures Squeeze Molina Healthcare's Q2 Earnings, Reflecting Industry-Wide Challenges

Cost Pressures Squeeze Molina Healthcare's Q2 Earnings, Reflecting Industry-Wide Challenges

Molina Healthcare, a major player in the health insurance industry, has released its second-quarter financial results, revealing ongoing pressures that mirror broader challenges faced by insurers across the sector. The company's performance underscores the delicate balance between premium rates and accelerating medical cost trends, prompting a reassessment of its full-year outlook.

NoahAI News7/24/2025
New Brain Pathway Targeted for Weight Loss Without GI Side Effects

New Brain Pathway Targeted for Weight Loss Without GI Side Effects

A groundbreaking study has unveiled a novel approach to weight loss that could potentially revolutionize obesity treatment. Scientists have successfully targeted a pathway deep in the brain to promote weight reduction in obese rodents without the gastrointestinal side effects commonly associated with current treatments.

NoahAI News7/24/2025
Waystar to Acquire Iodine Software for $1.25B, Boosting AI-Driven Revenue Cycle Management

Waystar to Acquire Iodine Software for $1.25B, Boosting AI-Driven Revenue Cycle Management

Waystar, a prominent healthcare payment software provider, has announced plans to acquire Iodine Software, an AI-driven revenue cycle management company, in a deal valued at $1.25 billion. This strategic move, Waystar's first acquisition since going public last year, aims to enhance its AI capabilities and expand its market presence in the healthcare technology sector.

NoahAI News7/24/2025
Community Health Systems Beats Q2 Estimates, CEO Announces Retirement

Community Health Systems Beats Q2 Estimates, CEO Announces Retirement

Community Health Systems (CHS) has reported better-than-expected second-quarter results for 2025, alongside the announcement of CEO Tim Hingtgen's retirement. The company's financial performance and leadership transition highlight significant developments in the for-profit healthcare sector.

NoahAI News7/24/2025
Zhen Li: From Reluctant Engineer to Pioneering siRNA Innovator at ADARx Pharmaceuticals

Zhen Li: From Reluctant Engineer to Pioneering siRNA Innovator at ADARx Pharmaceuticals

In a recent interview with BioSpace, Zhen Li, CEO of ADARx Pharmaceuticals, shared her journey from a rebellious science student to a leader in the burgeoning field of siRNA therapeutics. Li's story underscores the dynamic interplay between scientific innovation and engineering precision in modern biopharma.

NoahAI News7/24/2025
TCG Labs Soleil Secures $400M in Funding, Expands Global R&D Footprint

TCG Labs Soleil Secures $400M in Funding, Expands Global R&D Footprint

TCG Labs Soleil, a San Francisco-based biotech venture firm, has successfully raised $400 million in its latest funding round, matching the size of its inaugural fund from the previous year. This significant capital injection aims to bolster the company's ability to advance its portfolio of biotech companies and expand its research and development capabilities on a global scale.

NoahAI News7/24/2025
«1...8910...67»